Sagimet Biosciences (SGMT) Operating Margin (2023)
Sagimet Biosciences has reported Operating Margin over the past 1 years, most recently at 372.6% for Q3 2023.
- Quarterly results put Operating Margin at 372.6% for Q3 2023, changed N/A from a year ago — trailing twelve months through Jun 2024 was 1813.75% (changed N/A YoY), and the annual figure for FY2023 was 1537.0%, changed.
- Operating Margin for Q3 2023 was 372.6% at Sagimet Biosciences.
- Over the last five years, Operating Margin for SGMT hit a ceiling of 372.6% in Q3 2023 and a floor of 372.6% in Q3 2023.